<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE AUDITED
FINANCIAL STATEMENTS OF CIPHERGEN BIOSYSTEMS, INC. AS OF DECEMBER 31, 1998 AND
1999 AND FOR THE YEARS ENDED DECEMBER 31, 1997, 1998 AND 1999 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000926617
<NAME> CIPHERGEN BIOSYSTEMS, INC.
<MULTIPLIER> 1,000

                                                                       
<PERIOD-TYPE>                   YEAR                   YEAR                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997             DEC-31-1998             DEC-31-1999
<PERIOD-START>                             JAN-01-1997             JAN-01-1998             JAN-01-1999
<PERIOD-END>                               DEC-31-1997             DEC-01-1998             DEC-01-1999
<CASH>                                               0                   7,002                   2,799
<SECURITIES>                                         0                       0                       0
<RECEIVABLES>                                        0                   1,112                   1,098
<ALLOWANCES>                                         0                    (40)                   (100)
<INVENTORY>                                          0                     730                     722
<CURRENT-ASSETS>                                     0                   9,035                   4,841
<PP&E>                                               0                   1,479                   2,017
<DEPRECIATION>                                       0                   (688)                 (1,150)
<TOTAL-ASSETS>                                       0                  10,082                   6,147
<CURRENT-LIABILITIES>                                0                   2,419                   3,308
<BONDS>                                              0                       0                       0
<PREFERRED-MANDATORY>                                0                       0                       0
<PREFERRED>                                          0                  24,264                  25,339
<COMMON>                                             0                      16                      16
<OTHER-SE>                                           0                (16,998)                (23,296)
<TOTAL-LIABILITY-AND-EQUITY>                         0                  10,082                   6,147
<SALES>                                          1,283                   2,933                   5,010
<TOTAL-REVENUES>                                 1,283                   2,933                   5,010
<CGS>                                            1,001                   1,066                   1,669
<TOTAL-COSTS>                                    1,001                   1,066                   1,669
<OTHER-EXPENSES>                                 6,865                  10,034                  10,966
<LOSS-PROVISION>                                     0                       0                       0
<INTEREST-EXPENSE>                                 236                     488                     179
<INCOME-PRETAX>                                (6,809)                 (8,310)                 (7,681)
<INCOME-TAX>                                         0                       0                       0
<INCOME-CONTINUING>                            (6,809)                 (8,310)                 (7,681)
<DISCONTINUED>                                       0                       0                       0
<EXTRAORDINARY>                                      0                       0                       0
<CHANGES>                                            0                       0                       0
<NET-INCOME>                                   (6,809)                 (8,310)                 (7,681)
<EPS-BASIC>                                     (1.01)                  (0.72)                  (0.52)
<EPS-DILUTED>                                   (1.01)                  (0.72)                  (0.52)